Users Discontinuing Anti-Obesity Medications Put On Pounds at a Quadrupled Rate Than Dieters

Fresh analysis indicates that patients who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds far faster than those who halt conventional lifestyle regimens.

Published data in a major health publication points out that while obese individuals often shed about a fifth of their total mass while using the jabs, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.

"Users purchasing such drugs should be informed of the potential of quick weight regain when the medication is stopped," stated lead investigator Dr. Susan Jebb.

That rate of recovery implies a return to starting weight in about a year and a half.

Analyzing Therapies

The research, which examined 37 of studies involving thousands of participants, compared the outcomes of these new drugs with conventional dieting.

The team point out that individuals who shed pounds through diet and exercise typically have a slower creep back—approximately 0.1 kg a month—post-intervention.

The Reason for the Rapid Rebound

Experts suggest the mechanism of the drugs explains the amplified rebound.

GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Sustained high doses of GLP-1 levels far above than normal may cause the system to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this GLP-1 'fix' means appetite is unsuppressed, making binge eating a significant risk."

A Chronic Condition?

The NHS advise the injections for people with weight-linked health risks, accompanied by prescribed lifestyle changes.

Professionals contend that, considering the likelihood of relapse, the therapy should be considered long-term.

This view is reinforced by drug manufacturers, who state that the findings "emphasize the long-term character of obesity," akin to managing conditions like hypertension.

Patient Testimonies

Individuals who have come off the medication describe a intense return of cravings.

"It felt as if a trigger flipping and you're instantly extremely hungry," recalled a patient.

The struggle is worsened if patients have not established sustainable lifestyle or habit modifications during therapy.

Significant Adoption

Recent estimates indicate that millions of people in the UK have tried weight-loss jabs in the past year, with demand remaining high.

• Use is greater among females compared to men.
• The 40s and 50s demographic shows the highest usage rates.
• A large proportion access the medications through private prescriptions rather than public health services.

In conclusion, researchers emphasize that while these medications are potent agents for shedding pounds, they are not a permanent cure and long-term success likely depends on ongoing lifestyle management.